MyParkinsonsTeam

Yes, researchers are currently exploring new treatment strategies to protect dopamine-producing cells in the brain. One approach involves using a harmless virus to deliver gene therapy. Additionally, two new drugs, Prasinezumab and UCB0599, are being tested in clinical trials for their potential to slow the progression of Show Full Answer

Yes, researchers are currently exploring new treatment strategies to protect dopamine-producing cells in the brain. One approach involves using a harmless virus to deliver gene therapy. Additionally, two new drugs, Prasinezumab and UCB0599, are being tested in clinical trials for their potential to slow the progression of Parkinson’s disease. Prasinezumab is administered intravenously every four weeks, and UCB0599 is an oral drug. The clinical trial for UCB0599 is scheduled to be completed in 2024.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

4 Parkinson’s Advances: How Research Is Improving Treatment | MyParkinsonsTeam

Treatments for Parkinson’s and Parkinsonism | MyParkinsonsTeam